Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / CL B
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
4.97K
-
Shares change
-
-104K
-
Total reported value, excl. options
-
$2.85M
-
Value change
-
-$77.6M
-
Number of buys
-
1
-
Number of sells
-
-8
-
Price
-
$563.66
Significant Holders of BIO RAD LABS INC - CL B (BIOB) as of Q1 2022
12 filings reported holding BIOB - BIO RAD LABS INC - CL B as of Q1 2022.
BIO RAD LABS INC - CL B (BIOB) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.97K shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (2K shares), CSS LLC/IL (1.45K shares), MORGAN STANLEY (692 shares), LIBRA WEALTH LLC (500 shares), Gemmer Asset Management LLC (279 shares), WELLS FARGO & COMPANY/MN (56 shares), UBS Group AG (0 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares), Tikvah Management LLC (0 shares), and BANK OF AMERICA CORP /DE/ (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.